Grindwell Norton (GRINDWELL)

FairStock Score: 40/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• High return on capital: ROE 18.78%, ROCE 20.90%, D/E 0.04 shows capital discipline and financial strength.
• Established abrasives franchise with promoter holding 58.04%, aligning majority owner interest and supporting business moat.
• Consistent profitability: latest quarter sales ₹753 Cr and net profit ₹96 Cr indicates healthy margins; FCF ₹243 Cr.
• Solid financial health score: Piotroski F-Score 7/9, healthy cash generation and minimal leverage.
• Proven long-term growth: 5-year revenue CAGR 11.41%; profit growth 9.62%.

Concerns

• Valuation stretched: P/E 47.31, P/B 8.83, PEG 5.65; paying a heavy premium for moderate growth.
• Growth not fast enough to justify the multiple: sales growth 7.14% and profit growth 9.62%.
• Low dividend yield of 1.02% offers minimal downside cushion or shareholder income.
• FairStock Score 35/100 suggests a mixed risk-reward at the current price.

AI Analysis

Let me first acknowledge this is a high-quality business. Grindwell Norton earns 18.78% on equity and 20.90% on capital employed, with virtually no debt (D/E 0.04). That combination is rare. Abrasives have brand and customer-switching characteristics, reflected in consistent returns and a promoter stake of 58.04%. The company generated free cash flow of ₹243 Cr and latest quarter net profit of ₹96 Cr on sales of ₹753 Cr, a ~12.7% margin. Piotroski F-Score 7/9 confirms balance-sheet health. But Benjamin Graham taught me that no business is worth paying any price for. At ₹1,645.80, the market values it at ₹18,406 Cr, or 47.31 times earnings and 8.83 times book value. That is a heavy premium for a company whose sales grew 7.14% and profits 9.62%. Even the five-year revenue CAGR of 11.41% does not justify a PEG of 5.65. This is a wonderful stalwart, not a fast grower at this price. The current dividend yield of 1.02% offers little income support while waiting. I would call it a great company, but the price leaves no margin of safety. If it can compound earnings at 9-12% for a decade, today's buyer still might earn a mediocre return. For a retail investor, I'd prefer to wait for a better price or a genuine growth acceleration. The 52-week range shows it has fallen from ₹2,400; sometimes the market gives patient investors a second chance. Let the business prove it can grow into this valuation, then act. Until then, watch and wait.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer